B cell-specific deletion of Traf3 in mice (B-Traf3−/−) results in markedly enhanced B cell survival and substantially increases incidence of B cell lymphoma, implicating TRAF3 as a tumor suppressor2, 3. Here, TRAF3 is linked to B-cell non-Hodgkin lymphoma.